| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |